Research programme: small molecule therapeutics - Virna therapeutics
Latest Information Update: 28 Jun 2024
Price :
$50 *
At a glance
- Originator Virna Therapeutics
- Class Antivirals; Small molecules
- Mechanism of Action Peptide hydrolase inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported COVID 2019 infections